Nephrotic syndrome screening: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Nephrotic syndrome}} {{CMG}}; {{AE}} ==Overview== There is insufficient evidence to recommend routine screening for [disease/malignancy]. OR According to the..." |
No edit summary |
||
Line 2: | Line 2: | ||
{{Nephrotic syndrome}} | {{Nephrotic syndrome}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}}{{MJ}} | ||
==Overview== | ==Overview== | ||
There is insufficient evidence to recommend routine screening for | There is insufficient evidence to recommend routine screening for nephrotic syndrome. | ||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine screening for | There is insufficient evidence to recommend routine screening for nephrotic syndrome. | ||
==References== | ==References== |
Revision as of 13:11, 17 May 2018
Nephrotic Syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Nephrotic syndrome screening On the Web |
American Roentgen Ray Society Images of Nephrotic syndrome screening |
Risk calculators and risk factors for Nephrotic syndrome screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]
Overview
There is insufficient evidence to recommend routine screening for nephrotic syndrome.
Screening
There is insufficient evidence to recommend routine screening for nephrotic syndrome.